Literature DB >> 23138613

Clinical and histological prognostic factors for local recurrence and metastasis of cutaneous squamous cell carcinoma: analysis of a defined population.

Marieke H Roozeboom1, Bjorn G P M Lohman, Annet Westers-Attema, Patty J Nelemans, Anita A Botterweck, Arienne M W van Marion, Nicole W J Kelleners-Smeets.   

Abstract

Cutaneous squamous cell carcinomas (cSCC) can recur locally and can metastasize. The objective of this study was to identify clinical and histopathological prognostic factors for local recurrence and metastasis in cSCCs at any body site. Clinical and histopathological data were collected from 224 patients with cSCC. During the median follow-up period of 43 months (range 0-73 months) the cumulative probabilities of recurrence-free survival at 1, 2 and 4 years post-treatment were 98.0%, 96.9% and 94.7%, respectively, and for metastasis-free survival 98.1%, 97.0% and 95.9%, respectively. In univariate survival analyses, predictors for local recurrence were every millimetre increase in tumour diameter and in tumour thickness. Predictors for metastasis this was location on the ear, invasion of deeper structures, no surgical treatment, poor differentiation, every millimetre increase in tumour diameter and in tumour thickness. In multivariate survival analysis, every millimetre increase in both tumour diameter and tumour thickness were independent predictors for local recurrence as well as for metastasis and, therefore, it is important to report these in patients' files. Defining prognostic valuables is important for diagnostic work-up, treatment and follow-up for an individual patient.

Entities:  

Mesh:

Year:  2013        PMID: 23138613     DOI: 10.2340/00015555-1501

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  12 in total

Review 1.  [Classification of cutaneous squamous cell carcinoma : How do I recognise my high-risk patient?]

Authors:  Lukas Kofler
Journal:  Hautarzt       Date:  2019-11       Impact factor: 0.751

2.  Validating 4 Staging Systems for Cutaneous Squamous Cell Carcinoma Using Population-Based Data: A Nested Case-Control Study.

Authors:  Ingrid Roscher; Ragnhild S Falk; Linda Vos; Ole P F Clausen; Per Helsing; Petter Gjersvik; Trude E Robsahm
Journal:  JAMA Dermatol       Date:  2018-04-01       Impact factor: 10.282

Review 3.  Overview of the 8th Edition TNM Classification for Head and Neck Cancer.

Authors:  Shao Hui Huang; Brian O'Sullivan
Journal:  Curr Treat Options Oncol       Date:  2017-07

4.  Prognostic value of 18F-FDG PET/CT and MRI features in patients with high-risk and very-high-risk cutaneous squamous cell carcinoma.

Authors:  Masaya Kawaguchi; Hiroki Kato; Kanako Matsuyama; Yoshifumi Noda; Fuminori Hyodo; Masayuki Matsuo
Journal:  Br J Radiol       Date:  2022-01-07       Impact factor: 3.629

Review 5.  Malignant lesions of the ear.

Authors:  Antonella Tammaro; Ganiyat Adenike Ralitsa Adebanjo; Camilla Chello; Francesca Romana Parisella; Carmen Cantisani; Francesca Farnetani; Giovanni Pellacani
Journal:  Arch Dermatol Res       Date:  2021-11-18       Impact factor: 3.033

Review 6.  Risk Factors for Cutaneous Squamous Cell Carcinoma Recurrence, Metastasis, and Disease-Specific Death: A Systematic Review and Meta-analysis.

Authors:  Agnieszka K Thompson; Benjamin F Kelley; Larry J Prokop; M Hassan Murad; Christian L Baum
Journal:  JAMA Dermatol       Date:  2016-04       Impact factor: 10.282

7.  Malignant adnexal tumors of the skin: a single institution experience.

Authors:  Tolutope Oyasiji; Wei Tan; John Kane; Joseph Skitzki; Valerie Francescutti; Kilian Salerno; Nikhil I Khushalani
Journal:  World J Surg Oncol       Date:  2018-05-30       Impact factor: 2.754

8.  Sentinel lymph node biopsy for high-thickness cutaneous squamous cell carcinoma.

Authors:  Lukas Kofler; Katrin Kofler; Claudia Schulz; Helmut Breuninger; Hans-Martin Häfner
Journal:  Arch Dermatol Res       Date:  2020-05-08       Impact factor: 3.017

9.  Evidence-Based Consensus Recommendations for the Evolving Treatment of Patients with High-Risk and Advanced Cutaneous Squamous Cell Carcinoma.

Authors:  Guilherme Rabinowits; Michael R Migden; Todd E Schlesinger; Robert L Ferris; Morganna Freeman; Valerie Guild; Shlomo Koyfman; Anna C Pavlick; Neil Swanson; Gregory T Wolf; Scott M Dinehart
Journal:  JID Innov       Date:  2021-08-25

10.  Cutaneous Squamous Cell Carcinoma with Invasion through Ear Cartilage.

Authors:  Julie Boisen; C Helen Malone; Brent Kelly; Richard F Wagner
Journal:  Case Rep Dermatol Med       Date:  2016-05-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.